FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Amoxapine Tablets
Status: Currently in Shortage
»Date first posted: 12/19/2017
»Therapeutic Categories: Psychiatry

Expand all

Teva Pharmaceuticals (Reverified 07/11/2018)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg/1.0 unit (NDC 0591-5713-01) Available Other
50 mg/1.0 unit (NDC 0591-5714-01) Available Other
100 mg/1.0 unit (NDC 0591-5715-01) Available Other
150 mg/1.0 unit (NDC 0591-5716-30) Available Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English